ID   LSS_HUMAN               Reviewed;         732 AA.
AC   P48449; B4DJZ9; D3DSN0; E9PEI9; G5E9Q9; Q8IYL6; Q9UEZ1;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   28-JUN-2023, entry version 206.
DE   RecName: Full=Lanosterol synthase;
DE            EC=5.4.99.7 {ECO:0000269|PubMed:14766201, ECO:0000269|PubMed:26200341, ECO:0000269|PubMed:7639730};
DE   AltName: Full=2,3-epoxysqualene--lanosterol cyclase;
DE   AltName: Full=Oxidosqualene--lanosterol cyclase;
DE            Short=OSC;
DE            Short=hOSC;
GN   Name=LSS; Synonyms=OSC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND CATALYTIC ACTIVITY.
RC   TISSUE=Liver;
RX   PubMed=7639730; DOI=10.1006/bbrc.1995.2110;
RA   Baker C.H., Matsuda S.P.T., Liu D.R., Corey E.J.;
RT   "Molecular cloning of the human gene encoding lanosterol synthase from a
RT   liver cDNA library.";
RL   Biochem. Biophys. Res. Commun. 213:154-160(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal liver;
RX   PubMed=8593458; DOI=10.1248/bpb.18.1459;
RA   Sung C.K., Shibuya M., Sankawa U., Ebizuka Y.;
RT   "Molecular cloning of cDNA encoding human lanosterol synthase.";
RL   Biol. Pharm. Bull. 18:1459-1461(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANT VAL-642.
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10598817; DOI=10.1007/s004390051135;
RA   Roessler E., Mittaz L., Du Y., Scott H.S., Chang J., Rossier C.,
RA   Guipponi M., Matsuda S.P., Muenke M., Antonarakis S.E.;
RT   "Structure of the human lanosterol synthase gene and its analysis as a
RT   candidate for holoprosencephaly.";
RL   Hum. Genet. 105:489-495(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT VAL-642.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10830953; DOI=10.1038/35012518;
RA   Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S.,
RA   Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M.,
RA   Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A., Menzel U.,
RA   Delabar J., Kumpf K., Lehmann R., Patterson D., Reichwald K., Rump A.,
RA   Schillhabel M., Schudy A., Zimmermann W., Rosenthal A., Kudoh J.,
RA   Shibuya K., Kawasaki K., Asakawa S., Shintani A., Sasaki T., Nagamine K.,
RA   Mitsuyama S., Antonarakis S.E., Minoshima S., Shimizu N., Nordsiek G.,
RA   Hornischer K., Brandt P., Scharfe M., Schoen O., Desario A., Reichelt J.,
RA   Kauer G., Bloecker H., Ramser J., Beck A., Klages S., Hennig S.,
RA   Riesselmann L., Dagand E., Wehrmeyer S., Borzym K., Gardiner K.,
RA   Nizetic D., Francis F., Lehrach H., Reinhardt R., Yaspo M.-L.;
RT   "The DNA sequence of human chromosome 21.";
RL   Nature 405:311-319(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT VAL-642.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-5, CATALYTIC ACTIVITY, SUBUNIT, SUBCELLULAR LOCATION,
RP   AND FUNCTION.
RX   PubMed=14766201; DOI=10.1016/j.bbrc.2004.01.052;
RA   Ruf A., Muller F., D'Arcy B., Stihle M., Kusznir E., Handschin C.,
RA   Morand O.H., Thoma R.;
RT   "The monotopic membrane protein human oxidosqualene cyclase is active as
RT   monomer.";
RL   Biochem. Biophys. Res. Commun. 315:247-254(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 41-630 (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=8655142; DOI=10.1007/bf02281872;
RA   Young M., Chen H., Lalioti M.D., Antonarakis S.E.;
RT   "The human lanosterol synthase gene maps to chromosome 21q22.3.";
RL   Hum. Genet. 97:620-624(1996).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   FUNCTION, INVOLVEMENT IN CTRCT44, VARIANTS CTRCT44 ARG-581 AND SER-588,
RP   CHARACTERIZATION OF VARIANTS CTRCT44 ARG-581 AND SER-588, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=26200341; DOI=10.1038/nature14650;
RA   Zhao L., Chen X.J., Zhu J., Xi Y.B., Yang X., Hu L.D., Ouyang H.,
RA   Patel S.H., Jin X., Lin D., Wu F., Flagg K., Cai H., Li G., Cao G., Lin Y.,
RA   Chen D., Wen C., Chung C., Wang Y., Qiu A., Yeh E., Wang W., Hu X.,
RA   Grob S., Abagyan R., Su Z., Tjondro H.C., Zhao X.J., Luo H., Hou R.,
RA   Perry J.J., Gao W., Kozak I., Granet D., Li Y., Sun X., Wang J., Zhang L.,
RA   Liu Y., Yan Y.B., Zhang K.;
RT   "Lanosterol reverses protein aggregation in cataracts.";
RL   Nature 523:607-611(2015).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   VARIANTS CTRCT44 SER-342 AND CYS-629.
RX   PubMed=29016354; DOI=10.1515/jpem-2017-0101;
RA   Chen X., Liu L.;
RT   "Congenital cataract with LSS gene mutations: a new case report.";
RL   J. Pediatr. Endocrinol. Metab. 30:1231-1235(2017).
RN   [17]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, INVOLVEMENT IN HYPT14,
RP   INVOLVEMENT IN APMR4, VARIANTS HYPT14 VAL-102; PRO-248 AND SER-391,
RP   VARIANTS APMR4 141-TRP--PRO-732 DEL AND TYR-209, CHARACTERIZATION OF
RP   VARIANTS HYPT14 VAL-102; PRO-248 AND SER-391, AND CHARACTERIZATION OF
RP   VARIANTS APMR4 141-TRP--PRO-732 DEL AND TYR-209.
RX   PubMed=30401459; DOI=10.1016/j.ajhg.2018.09.011;
RA   Romano M.T., Tafazzoli A., Mattern M., Sivalingam S., Wolf S., Rupp A.,
RA   Thiele H., Altmueller J., Nuernberg P., Ellwanger J., Gambon R., Baumer A.,
RA   Kohlschmidt N., Metze D., Holdenrieder S., Paus R., Luetjohann D.,
RA   Frank J., Geyer M., Bertolini M., Kokordelis P., Betz R.C.;
RT   "Bi-allelic mutations in LSS, encoding lanosterol synthase, cause
RT   autosomal-recessive hypotrichosis simplex.";
RL   Am. J. Hum. Genet. 103:777-785(2018).
RN   [18]
RP   INVOLVEMENT IN APMR4, AND VARIANTS APMR4 ASP-12; CYS-14; PRO-260; CYS-286;
RP   SER-516; 604-ARG--PRO-732 DEL; ILE-652 AND LYS-705.
RX   PubMed=30723320; DOI=10.1038/s41436-019-0445-x;
RA   Besnard T., Sloboda N., Goldenberg A., Kuery S., Cogne B., Breheret F.,
RA   Trochu E., Conrad S., Vincent M., Deb W., Balguerie X., Barbarot S.,
RA   Baujat G., Ben-Omran T., Bursztejn A.C., Carmignac V., Datta A.N.,
RA   Delignieres A., Faivre L., Gardie B., Gueant J.L., Kuentz P., Lenglet M.,
RA   Nassogne M.C., Ramaekers V., Schnur R.E., Si Y., Torti E., Thevenon J.,
RA   Vabres P., Van Maldergem L., Wand D., Wiedemann A., Cariou B., Redon R.,
RA   Lamaziere A., Bezieau S., Feillet F., Isidor B.;
RT   "Biallelic pathogenic variants in the lanosterol synthase gene LSS involved
RT   in the cholesterol biosynthesis cause alopecia with intellectual
RT   disability, a rare recessive neuroectodermal syndrome.";
RL   Genet. Med. 21:2025-2035(2019).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEXES WITH LANOSTEROL AND RO
RP   48-807, SUBCELLULAR LOCATION, AND ACTIVE SITE.
RX   PubMed=15525992; DOI=10.1038/nature02993;
RA   Thoma R., Schulz-Gasch T., D'Arcy B., Benz J., Aebi J., Dehmlow H.,
RA   Hennig M., Stihle M., Ruf A.;
RT   "Insight into steroid scaffold formation from the structure of human
RT   oxidosqualene cyclase.";
RL   Nature 432:118-122(2004).
CC   -!- FUNCTION: Key enzyme in the cholesterol biosynthesis pathway. Catalyzes
CC       the cyclization of (S)-2,3 oxidosqualene to lanosterol, a reaction that
CC       forms the sterol nucleus (PubMed:14766201, PubMed:7639730,
CC       PubMed:26200341). Through the production of lanosterol may regulate
CC       lens protein aggregation and increase transparency (PubMed:26200341).
CC       {ECO:0000269|PubMed:14766201, ECO:0000269|PubMed:26200341,
CC       ECO:0000269|PubMed:7639730}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-2,3-epoxysqualene = lanosterol; Xref=Rhea:RHEA:14621,
CC         ChEBI:CHEBI:15441, ChEBI:CHEBI:16521; EC=5.4.99.7;
CC         Evidence={ECO:0000269|PubMed:14766201, ECO:0000269|PubMed:26200341,
CC         ECO:0000269|PubMed:7639730};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14622;
CC         Evidence={ECO:0000305|PubMed:14766201};
CC   -!- PATHWAY: Terpene metabolism; lanosterol biosynthesis; lanosterol from
CC       farnesyl diphosphate: step 3/3.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:14766201}.
CC   -!- INTERACTION:
CC       P48449; Q13520: AQP6; NbExp=3; IntAct=EBI-3930711, EBI-13059134;
CC       P48449; Q99828: CIB1; NbExp=3; IntAct=EBI-3930711, EBI-372594;
CC       P48449; Q14973: SLC10A1; NbExp=3; IntAct=EBI-3930711, EBI-3923031;
CC       P48449; Q3KNW5: SLC10A6; NbExp=3; IntAct=EBI-3930711, EBI-18159983;
CC       P48449; Q9NRX6: TMEM167B; NbExp=3; IntAct=EBI-3930711, EBI-17684533;
CC       P48449; Q8N661: TMEM86B; NbExp=3; IntAct=EBI-3930711, EBI-2548832;
CC       P48449; O95070: YIF1A; NbExp=3; IntAct=EBI-3930711, EBI-2799703;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:14766201, ECO:0000269|PubMed:15525992,
CC       ECO:0000269|PubMed:30401459}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:14766201, ECO:0000269|PubMed:15525992}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P48449-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P48449-2; Sequence=VSP_045407;
CC       Name=3;
CC         IsoId=P48449-3; Sequence=VSP_046188;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in the hair bulb, the
CC       outer root sheath and hair matrix of the hair follicle epithelium. Also
CC       detected in dermal papilla, epidermis, sweat glands, sebaceous glands,
CC       and blood vessels. {ECO:0000269|PubMed:30401459}.
CC   -!- DISEASE: Cataract 44 (CTRCT44) [MIM:616509]: An opacification of the
CC       crystalline lens of the eye that frequently results in visual
CC       impairment or blindness. Opacities vary in morphology, are often
CC       confined to a portion of the lens, and may be static or progressive. In
CC       general, the more posteriorly located and dense an opacity, the greater
CC       the impact on visual function. {ECO:0000269|PubMed:26200341,
CC       ECO:0000269|PubMed:29016354}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Hypotrichosis 14 (HYPT14) [MIM:618275]: A form of
CC       hypotrichosis, a condition characterized by the presence of less than
CC       the normal amount of hair and abnormal hair follicles and shafts, which
CC       are thin and atrophic. The extent of scalp and body hair involvement
CC       can be very variable, within as well as between families. HYPT14 is an
CC       autosomal recessive form characterized by sparse to absent lanugo-like
CC       scalp hair, sparse and brittle eyebrows, and sparse eyelashes and body
CC       hair. {ECO:0000269|PubMed:30401459}. Note=The disease is caused by
CC       variants affecting the gene represented in this entry.
CC   -!- DISEASE: Alopecia-intellectual disability syndrome 4 (APMR4)
CC       [MIM:618840]: An autosomal recessive disorder characterized by alopecia
CC       universalis, scaly skin, mild to severe intellectual disability,
CC       delayed or absent speech, and motor delay.
CC       {ECO:0000269|PubMed:30401459, ECO:0000269|PubMed:30723320}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the terpene cyclase/mutase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U22526; AAC50184.1; -; mRNA.
DR   EMBL; D63807; BAA09875.1; -; mRNA.
DR   EMBL; S81221; AAB36220.1; -; mRNA.
DR   EMBL; AJ239031; CAB42828.1; -; Genomic_DNA.
DR   EMBL; AJ239021; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239022; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239023; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239024; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239025; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239026; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239027; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239028; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239029; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AJ239030; CAB42828.1; JOINED; Genomic_DNA.
DR   EMBL; AK296313; BAG59011.1; -; mRNA.
DR   EMBL; AK226141; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AP001468; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001469; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471079; EAX09299.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09301.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09302.1; -; Genomic_DNA.
DR   EMBL; CH471079; EAX09303.1; -; Genomic_DNA.
DR   EMBL; BC035638; AAH35638.1; -; mRNA.
DR   EMBL; X87809; CAA61078.1; -; mRNA.
DR   CCDS; CCDS13733.1; -. [P48449-1]
DR   CCDS; CCDS46654.1; -. [P48449-3]
DR   CCDS; CCDS54489.1; -. [P48449-2]
DR   PIR; JC4194; JC4194.
DR   RefSeq; NP_001001438.1; NM_001001438.2. [P48449-1]
DR   RefSeq; NP_001138908.1; NM_001145436.1. [P48449-3]
DR   RefSeq; NP_001138909.1; NM_001145437.1. [P48449-2]
DR   RefSeq; NP_002331.3; NM_002340.5. [P48449-1]
DR   RefSeq; XP_016883835.1; XM_017028346.1.
DR   RefSeq; XP_016883836.1; XM_017028347.1.
DR   PDB; 1W6J; X-ray; 2.20 A; A=1-732.
DR   PDB; 1W6K; X-ray; 2.10 A; A=1-732.
DR   PDBsum; 1W6J; -.
DR   PDBsum; 1W6K; -.
DR   AlphaFoldDB; P48449; -.
DR   SMR; P48449; -.
DR   BioGRID; 110225; 66.
DR   IntAct; P48449; 25.
DR   MINT; P48449; -.
DR   STRING; 9606.ENSP00000380837; -.
DR   BindingDB; P48449; -.
DR   ChEMBL; CHEMBL3593; -.
DR   DrugBank; DB03696; Lanosterol.
DR   DrugBank; DB02016; R048-8071.
DR   GuidetoPHARMACOLOGY; 2434; -.
DR   SwissLipids; SLP:000001308; -. [P48449-1]
DR   GlyGen; P48449; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P48449; -.
DR   PhosphoSitePlus; P48449; -.
DR   SwissPalm; P48449; -.
DR   BioMuta; LSS; -.
DR   DMDM; 1352387; -.
DR   EPD; P48449; -.
DR   jPOST; P48449; -.
DR   MassIVE; P48449; -.
DR   MaxQB; P48449; -.
DR   PaxDb; P48449; -.
DR   PeptideAtlas; P48449; -.
DR   ProteomicsDB; 19902; -.
DR   ProteomicsDB; 34015; -.
DR   ProteomicsDB; 55893; -. [P48449-1]
DR   Antibodypedia; 24599; 185 antibodies from 28 providers.
DR   DNASU; 4047; -.
DR   Ensembl; ENST00000356396.8; ENSP00000348762.3; ENSG00000160285.15. [P48449-1]
DR   Ensembl; ENST00000397728.8; ENSP00000380837.2; ENSG00000160285.15. [P48449-1]
DR   Ensembl; ENST00000457828.6; ENSP00000409191.2; ENSG00000160285.15. [P48449-2]
DR   Ensembl; ENST00000522411.5; ENSP00000429133.1; ENSG00000160285.15. [P48449-3]
DR   GeneID; 4047; -.
DR   KEGG; hsa:4047; -.
DR   MANE-Select; ENST00000397728.8; ENSP00000380837.2; NM_002340.6; NP_002331.3.
DR   UCSC; uc002zij.4; human. [P48449-1]
DR   AGR; HGNC:6708; -.
DR   CTD; 4047; -.
DR   DisGeNET; 4047; -.
DR   GeneCards; LSS; -.
DR   HGNC; HGNC:6708; LSS.
DR   HPA; ENSG00000160285; Low tissue specificity.
DR   MalaCards; LSS; -.
DR   MIM; 600909; gene.
DR   MIM; 616509; phenotype.
DR   MIM; 618275; phenotype.
DR   MIM; 618840; phenotype.
DR   neXtProt; NX_P48449; -.
DR   OpenTargets; ENSG00000160285; -.
DR   Orphanet; 2850; Alopecia-intellectual disability syndrome.
DR   Orphanet; 1366; Autosomal recessive palmoplantar keratoderma and congenital alopecia.
DR   Orphanet; 55654; Hypotrichosis simplex.
DR   Orphanet; 98994; Total early-onset cataract.
DR   PharmGKB; PA30473; -.
DR   VEuPathDB; HostDB:ENSG00000160285; -.
DR   eggNOG; KOG0497; Eukaryota.
DR   GeneTree; ENSGT00390000011570; -.
DR   HOGENOM; CLU_009074_2_1_1; -.
DR   InParanoid; P48449; -.
DR   OMA; CWARQTI; -.
DR   OrthoDB; 2712461at2759; -.
DR   PhylomeDB; P48449; -.
DR   TreeFam; TF300406; -.
DR   BioCyc; MetaCyc:HS08480-MON; -.
DR   BRENDA; 5.4.99.7; 2681.
DR   PathwayCommons; P48449; -.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   SignaLink; P48449; -.
DR   UniPathway; UPA00767; UER00753.
DR   BioGRID-ORCS; 4047; 44 hits in 1173 CRISPR screens.
DR   ChiTaRS; LSS; human.
DR   EvolutionaryTrace; P48449; -.
DR   GeneWiki; Lanosterol_synthase; -.
DR   GenomeRNAi; 4047; -.
DR   Pharos; P48449; Tchem.
DR   PRO; PR:P48449; -.
DR   Proteomes; UP000005640; Chromosome 21.
DR   RNAct; P48449; protein.
DR   Bgee; ENSG00000160285; Expressed in mucosa of stomach and 96 other tissues.
DR   ExpressionAtlas; P48449; baseline and differential.
DR   Genevisible; P48449; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0005811; C:lipid droplet; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0000250; F:lanosterol synthase activity; IMP:UniProtKB.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0031647; P:regulation of protein stability; IMP:UniProtKB.
DR   GO; GO:0006694; P:steroid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0016104; P:triterpenoid biosynthetic process; IEA:InterPro.
DR   CDD; cd02892; SQCY_1; 1.
DR   Gene3D; 1.50.10.20; -; 2.
DR   Gene3D; 6.20.120.20; -; 1.
DR   InterPro; IPR032696; SQ_cyclase_C.
DR   InterPro; IPR032697; SQ_cyclase_N.
DR   InterPro; IPR018333; Squalene_cyclase.
DR   InterPro; IPR002365; Terpene_synthase_CS.
DR   InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR   PANTHER; PTHR11764:SF20; LANOSTEROL SYNTHASE; 1.
DR   PANTHER; PTHR11764; TERPENE CYCLASE/MUTASE FAMILY MEMBER; 1.
DR   Pfam; PF13243; SQHop_cyclase_C; 1.
DR   Pfam; PF13249; SQHop_cyclase_N; 1.
DR   SFLD; SFLDG01016; Prenyltransferase_Like_2; 1.
DR   SUPFAM; SSF48239; Terpenoid cyclases/Protein prenyltransferases; 2.
DR   PROSITE; PS01074; TERPENE_SYNTHASES; 1.
DR   TIGRFAMs; TIGR01787; squalene_cyclas; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cataract;
KW   Direct protein sequencing; Disease variant; Endoplasmic reticulum;
KW   Hypotrichosis; Intellectual disability; Isomerase; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Reference proteome; Repeat;
KW   Steroid biosynthesis.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:14766201,
FT                   ECO:0007744|PubMed:22814378"
FT   CHAIN           2..732
FT                   /note="Lanosterol synthase"
FT                   /id="PRO_0000072659"
FT   REPEAT          77..121
FT                   /note="PFTB 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          124..165
FT                   /note="PFTB 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          424..468
FT                   /note="PFTB 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          483..528
FT                   /note="PFTB 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          560..600
FT                   /note="PFTB 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          612..653
FT                   /note="PFTB 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          670..712
FT                   /note="PFTB 7"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        455
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000305|PubMed:15525992"
FT   SITE            387
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000269|PubMed:15525992"
FT   SITE            444
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000269|PubMed:15525992"
FT   SITE            581
FT                   /note="Transition state stabilizer"
FT                   /evidence="ECO:0000269|PubMed:15525992"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   VAR_SEQ         1..80
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_045407"
FT   VAR_SEQ         133..143
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046188"
FT   VARIANT         12
FT                   /note="G -> D (in APMR4; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30723320"
FT                   /id="VAR_084019"
FT   VARIANT         14
FT                   /note="Y -> C (in APMR4; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30723320"
FT                   /id="VAR_084020"
FT   VARIANT         102
FT                   /note="L -> V (in HYPT14; the protein is present in the ER
FT                   but also mislocalized to the cytoplasm)"
FT                   /evidence="ECO:0000269|PubMed:30401459"
FT                   /id="VAR_081921"
FT   VARIANT         141..732
FT                   /note="Missing (in APMR4; loss of protein expression)"
FT                   /evidence="ECO:0000269|PubMed:30401459"
FT                   /id="VAR_081922"
FT   VARIANT         175
FT                   /note="R -> Q (in dbSNP:rs2839158)"
FT                   /id="VAR_024648"
FT   VARIANT         209
FT                   /note="N -> Y (in APMR4; changed localization; the protein
FT                   is present in the ER but is also mislocalized to the
FT                   cytoplasm; dbSNP:rs754230211)"
FT                   /evidence="ECO:0000269|PubMed:30401459"
FT                   /id="VAR_081923"
FT   VARIANT         248
FT                   /note="L -> P (in HYPT14; changed localization; the protein
FT                   is present in the ER but is also mislocalized to the
FT                   cytoplasm; dbSNP:rs1260995701)"
FT                   /evidence="ECO:0000269|PubMed:30401459"
FT                   /id="VAR_081924"
FT   VARIANT         260
FT                   /note="R -> P (in APMR4; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30723320"
FT                   /id="VAR_084021"
FT   VARIANT         286
FT                   /note="Y -> C (in APMR4; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30723320"
FT                   /id="VAR_084022"
FT   VARIANT         310
FT                   /note="H -> R (in dbSNP:rs34115287)"
FT                   /id="VAR_052057"
FT   VARIANT         342
FT                   /note="I -> S (in CTRCT44; associated with hypotrichosis;
FT                   unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:29016354"
FT                   /id="VAR_084023"
FT   VARIANT         391
FT                   /note="F -> S (in HYPT14; changed localization; the protein
FT                   is present in the ER but is also mislocalized to the
FT                   cytoplasm; dbSNP:rs1249530918)"
FT                   /evidence="ECO:0000269|PubMed:30401459"
FT                   /id="VAR_081925"
FT   VARIANT         516
FT                   /note="N -> S (in APMR4; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30723320"
FT                   /id="VAR_084024"
FT   VARIANT         581
FT                   /note="W -> R (in CTRCT44; loss of lanosterol synthase
FT                   activity; dbSNP:rs864622780)"
FT                   /evidence="ECO:0000269|PubMed:26200341"
FT                   /id="VAR_075664"
FT   VARIANT         588
FT                   /note="G -> S (in CTRCT44; loss of lanosterol synthase
FT                   activity; dbSNP:rs561449819)"
FT                   /evidence="ECO:0000269|PubMed:26200341"
FT                   /id="VAR_075665"
FT   VARIANT         604..732
FT                   /note="Missing (in APMR4; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30723320"
FT                   /id="VAR_084025"
FT   VARIANT         614
FT                   /note="R -> W (in dbSNP:rs35785446)"
FT                   /id="VAR_052058"
FT   VARIANT         629
FT                   /note="W -> C (in CTRCT44; associated with hypotrichosis;
FT                   unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:29016354"
FT                   /id="VAR_084026"
FT   VARIANT         642
FT                   /note="L -> V (in dbSNP:rs2254524)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.5"
FT                   /id="VAR_021522"
FT   VARIANT         652
FT                   /note="T -> I (in APMR4; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30723320"
FT                   /id="VAR_084027"
FT   VARIANT         688
FT                   /note="P -> L (in dbSNP:rs17293705)"
FT                   /id="VAR_052059"
FT   VARIANT         705
FT                   /note="T -> K (in APMR4; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30723320"
FT                   /id="VAR_084028"
FT   CONFLICT        348
FT                   /note="W -> R (in Ref. 4; CAB42828)"
FT                   /evidence="ECO:0000305"
FT   HELIX           22..24
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          25..30
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          33..38
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          40..45
FT                   /evidence="ECO:0007829|PDB:1W6J"
FT   HELIX           50..56
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   TURN            61..63
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           73..85
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          101..103
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           104..115
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           123..134
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           151..163
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           171..182
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           186..188
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           191..199
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           205..207
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           213..217
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           226..228
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           231..245
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           254..260
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           268..270
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           274..276
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           282..284
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           291..305
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           309..330
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           337..351
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           356..363
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           366..368
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          369..372
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          375..378
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          380..382
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           385..398
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           401..403
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           405..407
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           408..421
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           430..433
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          443..445
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   TURN            447..449
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           454..470
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           480..491
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          502..504
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           510..515
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           531..547
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           553..570
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          580..584
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           585..598
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           610..620
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           634..638
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           649..661
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           667..680
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          694..696
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   TURN            697..699
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   STRAND          700..702
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           707..722
FT                   /evidence="ECO:0007829|PDB:1W6K"
FT   HELIX           727..729
FT                   /evidence="ECO:0007829|PDB:1W6K"
SQ   SEQUENCE   732 AA;  83309 MW;  E4708A5AE53585ED CRC64;
     MTEGTCLRRR GGPYKTEPAT DLGRWRLNCE RGRQTWTYLQ DERAGREQTG LEAYALGLDT
     KNYFKDLPKA HTAFEGALNG MTFYVGLQAE DGHWTGDYGG PLFLLPGLLI TCHVARIPLP
     AGYREEIVRY LRSVQLPDGG WGLHIEDKST VFGTALNYVS LRILGVGPDD PDLVRARNIL
     HKKGGAVAIP SWGKFWLAVL NVYSWEGLNT LFPEMWLFPD WAPAHPSTLW CHCRQVYLPM
     SYCYAVRLSA AEDPLVQSLR QELYVEDFAS IDWLAQRNNV APDELYTPHS WLLRVVYALL
     NLYEHHHSAH LRQRAVQKLY EHIVADDRFT KSISIGPISK TINMLVRWYV DGPASTAFQE
     HVSRIPDYLW MGLDGMKMQG TNGSQIWDTA FAIQALLEAG GHHRPEFSSC LQKAHEFLRL
     SQVPDNPPDY QKYYRQMRKG GFSFSTLDCG WIVSDCTAEA LKAVLLLQEK CPHVTEHIPR
     ERLCDAVAVL LNMRNPDGGF ATYETKRGGH LLELLNPSEV FGDIMIDYTY VECTSAVMQA
     LKYFHKRFPE HRAAEIRETL TQGLEFCRRQ QRADGSWEGS WGVCFTYGTW FGLEAFACMG
     QTYRDGTACA EVSRACDFLL SRQMADGGWG EDFESCEERR YLQSAQSQIH NTCWAMMGLM
     AVRHPDIEAQ ERGVRCLLEK QLPNGDWPQE NIAGVFNKSC AISYTSYRNI FPIWALGRFS
     QLYPERALAG HP
//
